8 de diciembre de 2015 / 17:13 / en 2 años

BRIEF-Abivax announces ABX203 was granted Cuban marketing authorization

Dec 8 (Reuters) - Abivax SA :

* ABX203 granted Cuban marketing authorization to treat chronic Hepatitis B under the trade name HeberNasvac Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below